Protective and bronchodilator effects of prostaglandin E and salbutamol in aspirin-induced asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 153, Issue 2, 1996, Pages 567-571

  Szczeklik, Andrzej ^a   Mastalerz, Lucyna ^b   Nizankowska, Ewa ^b   Cmiel, Adam ^b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; AMINOPHYLLINE; MISOPROSTOL; PREDNISONE; PROSTAGLANDIN E; PROSTAGLANDIN E1; PROSTAGLANDIN E2; SALBUTAMOL; STEROID;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; BRONCHUS REACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; INHALATIONAL DRUG ADMINISTRATION; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL;

EID: 0030061398     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.153.2.8564099     Document Type: Article

References (35)

1. van Overveld, F. J., P. G. Jorens, W. A. De Backer, M. Rampart, L. Bossaert, and P. A. Vermeire. 1992. Release of arachidonic acid metabolites from isolated human alveolar type II cells. Prostaglandins 44:101-110.
2. Peters, S. P., E. S. Schulman, D. W. MacGlashan, R. P. Schleimer, H. H. Newball, and L. M. Lichtenstein. 1982. Pharmacological and biochemical studies of human lung mast cells. J. Allergy Clin. Immunol. 69:150.
3. Gryglewski, R. J., A. Szczeklik, and M. Wandzilak. 1987. The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylanine. Biochem. Pharmacol. 36:4209-4213.
4. 2. J. Immunol. 145:2616-2625.
5. 2: apparent correlation with in vivo modulation of mediator release. Proc. Natl. Acad. Sci. U.S.A. 85:2315-2319.
6. 2 on airway conductance in healthy subjects and asthmatic patients. Am. Rev. Respir. Dis. 111:313-320.
7. 2 on normal airways smooth muscle in vivo. Thorax 37:918-922.
8. Pasargiklian, M., S. Bianco, L. Allergra, N. E. Moavero, G. Petrigni, M. Robuschi, and A. Grugni. 1977. Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. Respiration 34: 79-91.
9. 2 on allergen-induced asthma. Am. Rev. Respir. Dis. 148:87-90.
10. 2 on bronchial reactivity to sodium metabisulphite and methacholine in subjects with asthma. Thorax 46:633-637.
11. 2 on exercise-induced bronchoconstriction in asthmatic subjects. Am. J. Respir. Crit. Care Med. 149:1138-1141.
12. Szczeklik, A. 1992. Aspirin-induced asthma. In J. R. Vane and R. M. Botting, editors. Aspirin and Other Salicylates. Chapman & Hall Medical, New York. 548-575.
13. Lee, T. H. 1992. Mechanism of aspirin sensitivity. Am. Rev. Respir. Dis. 145:34-36.
14. 2 and histamine in different types of asthma. Respiration 34:323-327.
15. Sladek, K., R. Dworski, J. Soja, J. R. Sheller, E. Nizankowska, J. A. Oates, and A. Szczeklik. 1994. Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am. J. Respir. Crit. Care Med. 149:940-946.
16. Szczeklik, A. 1988. Aspirin-induced asthma as a viral disease. Clin. Allergy 18:15-20.
17. Dahlen, B. 1993. Leukotrienes as Mediators of Asthma Induced by Aspirin and Allergy. Karolinska Institute Publishers, Stockholm.
18. Bland, J. M., and D. G. Altman. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310.
19. 1 on the airway responsiveness in asthmatic subjects. Pulmonary Pharmacol. 2:121-124.
20. Sladek, K., and A. Szczeklik. 1993. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur. Respir. J. 6:391-399.
21. 4 in subjects with aspirin-induced asthma. Am. Rev. Respir. Dis. 140:148-153.
22. 2 in normal man. Br. J. Clin. Pharmacol. 12:731-735.
23. 2-agonists: greater protection against adenosine monophosphate than metacholine-induced bronchoconstriction in asthma. Am. J. Respir. Crit. Care Med. 150:381-387.
24. Bosso, J. V., L. B. Schwartz, and D. D. Stevenson. 1991. Tryptase and histamine release during aspirin-induced respiratory reactions. J. Allergy Clin. Immunol. 88:830-837.
25. Szczeklik, A., and M. Serwonska. 1979. Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine. Thorax 34:654-657.
26. Philips, G. D., R. Foord, and S. T. Holgate. 1989. Inhaled lysine-aspirin as a bronchoprovocation procedure in aspirin-induced asthma: its repeatability, absence of late-phase reaction and the role of histamine. J. Allergy Clin. Immunol. 84:232-241.
27. Kuehl, F. A., W. H. Dougherty, and E. A. Ham. 1984. Interactions between prostaglandins and leukotrienes. Biochem. Pharmacol. 33:1-5.
28. 2 mechanism. J. Immunol. 151:2096-2104.
29. Butchers, P. R., C. J. Vardey, and M. Johnson. 1991. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br. J. Pharmacol. 104:672-676.
30. Nizankowska, E., G. Czerniawska-Mysik, and A. Szczeklik. 1986. Lack of effect of prostacyclin on aspirin-induced asthma. Eur. J. Respir. Dis. 69:363-368.
31. Hall, I. P., and A. E. Tattersfield. 1992. Beta-agonists. In T. J. H. Clark, S. Godfrey, and T. H. Lee, editors. Asthma, 3rd ed. Chapman & Hall, London. 341-351.
32. Christie, P. E., C. M. Smith, and T. H. Lee. 1991. The potent and selective sulidopeptide leukotriene antagonist, SK and F 104353, inhibits aspirin-induced asthma. Am. Rev. Respir. Dis. 144:957-958.
33. Dahlen, B., M. Kumlin, D. M. Margolskee, C. Larsson, H. Blomqvist, V. C. Williams, O. Zetterstrom, and S.-E. Dahlen. 1993. The leukotriene receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics. Eur. Respir. J. 6:1018-1026.
34. Israel, E., A. R. Fischer, M. A. Rosenberg, C. M. Lilly, J. C. Callery, J. Shapiro, J. Cohn, P. Rubin, and J. Drazen. 1993. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am. Rev. Respir. Dis. 148:1447-1451.
35. Dahl, R. 1981. Oral and inhaled sodium cromoglycate in challenge test with food allergens or acetylsalicylic acid. Allergy 36:161-165.